DuoTrav® Eye Drops As Replacement Therapy Program

Alcon

Status and phase: Completed; Phase 4

Conditions: Open-angle Glaucoma; Ocular Hypertension

Treatments: Drug: DuoTrav

Study type: Interventional

Funder types: Industry

Identifiers

NCT00828906

DART-2

Details and patient eligibility

About

To evaluate the effectiveness of DuoTrav Eye Drops in gaining or maintaining control of target Intraocular Pressures (tIOP) in patients diagnosed with, and being treated for, open-angle glaucoma (OAG) or ocular hypertension (OH).

Enrollment: 128 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with OAG or OH for whom single agent therapy provides insufficient intraocular pressure reduction

Exclusion criteria

• None

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

128 participants in 1 patient group

1

Experimental group

Description:

DuoTrav

Treatment:

Drug: DuoTrav